PURPOSE: We are currently developing a neurosurgical robotic system that facilitates access to residual tumors and improves brain tumor removal surgical outcomes. The system combines conventional and robotic surgery allowing for a quick conversion between the procedures. This concept requires a new master console that can be positioned at the surgical bedside and be sterilized. METHODS: The master console was developed using new technologies, such as a parallel mechanism and pneumatic sensors. The parallel mechanism is a purely passive 5-DOF (degrees of freedom) joystick based on the author's haptic research. The parallel mechanism enables motion input of conventional brain tumor removal surgery with a compact, intuitive interface that can be used in a conventional surgical environment. In addition, the pneumatic sensors implemented on the mechanism provide an intuitive interface and electrically isolate the tool parts from the mechanism so they can be easily sterilized. RESULTS: The 5-DOF parallel mechanism is compact (17 cm width, 19cm depth, and 15cm height), provides a 505,050 mm and 90° workspace and is highly backdrivable (0.27N of resistance force representing the surgical motion). The evaluation tests revealed that the pneumatic sensors can properly measure the suction strength, grasping force, and hand contact. In addition, an installability test showed that the master console can be used in a conventional surgical environment. CONCLUSION: The proposed master console design was shown to be feasible for operative neurosurgery based on comprehensive testing. This master console is currently being tested for master-slave control with a surgical robotic system.
PURPOSE: We are currently developing a neurosurgical robotic system that facilitates access to residual tumors and improves brain tumor removal surgical outcomes. The system combines conventional and robotic surgery allowing for a quick conversion between the procedures. This concept requires a new master console that can be positioned at the surgical bedside and be sterilized. METHODS: The master console was developed using new technologies, such as a parallel mechanism and pneumatic sensors. The parallel mechanism is a purely passive 5-DOF (degrees of freedom) joystick based on the author's haptic research. The parallel mechanism enables motion input of conventional brain tumor removal surgery with a compact, intuitive interface that can be used in a conventional surgical environment. In addition, the pneumatic sensors implemented on the mechanism provide an intuitive interface and electrically isolate the tool parts from the mechanism so they can be easily sterilized. RESULTS: The 5-DOF parallel mechanism is compact (17 cm width, 19cm depth, and 15cm height), provides a 505,050 mm and 90° workspace and is highly backdrivable (0.27N of resistance force representing the surgical motion). The evaluation tests revealed that the pneumatic sensors can properly measure the suction strength, grasping force, and hand contact. In addition, an installability test showed that the master console can be used in a conventional surgical environment. CONCLUSION: The proposed master console design was shown to be feasible for operative neurosurgery based on comprehensive testing. This master console is currently being tested for master-slave control with a surgical robotic system.
Authors: Massimo Cossu; Francesco Cardinale; Laura Castana; Alberto Citterio; Stefano Francione; Laura Tassi; Alim L Benabid; Giorgio Lo Russo Journal: Neurosurgery Date: 2005-10 Impact factor: 4.654
Authors: Junichi Tokuda; Gregory S Fischer; Xenophon Papademetris; Ziv Yaniv; Luis Ibanez; Patrick Cheng; Haiying Liu; Jack Blevins; Jumpei Arata; Alexandra J Golby; Tina Kapur; Steve Pieper; Everette C Burdette; Gabor Fichtinger; Clare M Tempany; Nobuhiko Hata Journal: Int J Med Robot Date: 2009-12 Impact factor: 2.547
Authors: Martin Klemm; Thomas Kirchner; Janek Gröhl; Dominique Cheray; Marco Nolden; Alexander Seitel; Harald Hoppe; Lena Maier-Hein; Alfred M Franz Journal: Int J Comput Assist Radiol Surg Date: 2016-09-29 Impact factor: 2.924